Novartis Won’t Move Swiss Research Jobs, Jimenez Tells NZZ
Novartis AG (NOVN), which is investing $1 billion to build a research and development center in Shanghai, won’t move highly-qualified jobs away from Switzerland, Chief Executive Officer Joe Jimenez told NZZ am Sonntag.
The company wants to tap the “enormous supply of talent” in China, Jimenez told the newspaper in an interview.
To contact the reporters on this story: Elena Logutenkova in Zurich at firstname.lastname@example.org
To contact the editors responsible for this story: Frank Connelly at email@example.com;
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.